As the global diabetic population crosses the half-a-billion mark, a silent revolution is taking place in the pharmaceutical industry—biosimilar insulin is gaining major traction. Once considered a risky bet against branded biologics, Insulin Biosimilars Market is now on an impressive growth trajectory, fueled by affordability, innovation, and strong regulatory support. 💉 What...